Monday U.S. Featured Earnings Avid Bioservices, Inc. (NASDAQ: CDMO) (Q4) EPS of two ...
Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.
The specialty healthcare services provider had a fiscal fourth quarter to forget.
The CDMO released fourth-quarter and fiscal 2023 earnings.
September S&P 500 futures (ESU23) are down -0.19%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.29% this morning after three major U.S. benchmark indices ended the regular session lower...
Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodies,
The bio-manufacturer's ongoing expansion efforts are a hit with investors.
CDMO earnings call for the period ending June 30, 2022.
CDMO earnings call for the period ending March 31, 2022.
-- Recorded Fourth Quarter and Full Fiscal Year Revenue of $31 Million and $120 Million, Respectively -- -- Signed $44 Million in Net New Business...